JPH0284932A - Apparatus for estimating manifestation itself of side effect in patient during dialytic treatment - Google Patents
Apparatus for estimating manifestation itself of side effect in patient during dialytic treatmentInfo
- Publication number
- JPH0284932A JPH0284932A JP1152015A JP15201589A JPH0284932A JP H0284932 A JPH0284932 A JP H0284932A JP 1152015 A JP1152015 A JP 1152015A JP 15201589 A JP15201589 A JP 15201589A JP H0284932 A JPH0284932 A JP H0284932A
- Authority
- JP
- Japan
- Prior art keywords
- signal
- prediction
- value
- patient
- rating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 13
- 230000000004 hemodynamic effect Effects 0.000 claims abstract description 10
- 238000004364 calculation method Methods 0.000 claims abstract description 9
- 238000000502 dialysis Methods 0.000 claims description 20
- 238000012545 processing Methods 0.000 claims description 18
- 230000017531 blood circulation Effects 0.000 claims description 7
- 238000005259 measurement Methods 0.000 claims description 5
- 230000011664 signaling Effects 0.000 claims description 3
- 230000005856 abnormality Effects 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 238000012417 linear regression Methods 0.000 abstract description 4
- 230000000747 cardiac effect Effects 0.000 abstract 2
- 238000007599 discharging Methods 0.000 abstract 1
- 238000010586 diagram Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000010606 normalization Methods 0.000 description 6
- 230000004872 arterial blood pressure Effects 0.000 description 4
- 238000010304 firing Methods 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241001325280 Tricardia watsonii Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000002425 cardiocirculatory effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
- A61M2230/06—Heartbeat rate only
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- External Artificial Organs (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
【発明の詳細な説明】
[産業の利用分野]
本発明は、透析治療を受けている患者体内の副作用発現
自体を予測する予測装置に関する。特に、本発明は、透
析治療を受けている患者を監視することを可能にしかつ
、例えば、吐き気、嘔吐(nausea、vogiit
ino ) 、低血圧症、頭痛、とりわけ、虚脱などの
ような好ましくない副作用の発現を予測する目的を有す
る予測装置に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a prediction device that predicts the occurrence of side effects within a patient undergoing dialysis treatment. In particular, the invention makes it possible to monitor patients undergoing dialysis treatment and to detect symptoms such as nausea, vomiting, etc.
The present invention relates to a prediction device having the purpose of predicting the occurrence of undesirable side effects such as hypotension, headache, and in particular collapse.
[従来の技術1
現下の状況においても、透析中の副作用の発現を回避す
る問題は扱われている、しかし、いまだ満足するように
は解決されておらず、次に掲げる三つの基本的な介入手
順の1つによっている次第である。[Prior art 1] Even in the current situation, the problem of avoiding the occurrence of side effects during dialysis has been addressed, but it has not yet been solved satisfactorily, and the following three basic interventions are needed: It depends on one of the steps.
第1の手順によれば、患者は、オペレータ、通常は看護
婦の側において動脈血圧、心拍数、及び場合によっては
体重減少を(半時間ごと、又は1時間ごとの)周期的測
定を行うことによって監視される。According to the first step, the patient undergoes periodic (half-hourly or hourly) measurements of arterial blood pressure, heart rate, and possibly weight loss at the operator's, usually a nurse's, side. monitored by.
云うまでもなく、この檻視は、不連続的かつ断続的であ
り、また監視の責任はオペレータに専ら任せられており
、オペレータは患者の状態の視覚的評定に従い介入し又
は患者自身の訴えに従い介入することさえもある。明ら
かに、この手順では、好機における矯正的な介入は不可
能であり、したがって、多くの場合極めて突発的に現れ
る一患者のあらゆる病状を防止できるには至らない。Needless to say, this cage vision is discontinuous and intermittent, and the responsibility for monitoring is left solely to the operator, who may intervene according to a visual assessment of the patient's condition or according to the patient's own complaints. They may even intervene. Obviously, this procedure does not allow corrective intervention at opportune times and therefore falls short of preventing all pathologies in a patient, which often appear very suddenly.
第2の手順は、生理透析過程の知識を利用して透析器械
類がその伴う擾乱作用のおそれを最少にして治療を遂行
できるようにこれらの器械類の構造を調節することであ
る。その結果は、上述の第1の介入手順に従って得られ
る結果よりも明確に優れている。The second step is to use knowledge of the physiological dialysis process to adjust the structure of dialysis equipment so that it can perform the treatment with minimal risk of associated disturbances. The results are clearly superior to those obtained according to the first intervention procedure described above.
しかしながら、器械によっては、その患者自身から到来
する何らかの信号を利用しないで、透析を受でいる患者
にとって(理論的基礎において)最適であると考えられ
ているパラメータに可能な限り近い特定の治療パラメー
タを得るようにプログラムされているために、正確に虚
脱(確かに最も特徴的かつ最も酷しい副作用)の発現を
防止することは依然として不可能である。なし得る矯正
的介入ないし予防的な介入は、ある場合には、オペレー
タの自由裁量に任されることさえもある。However, some instruments do not rely on any signals coming from the patient himself, but rather determine specific treatment parameters as close as possible to those considered (on a theoretical basis) to be optimal for the patient undergoing dialysis. It remains impossible to precisely prevent the development of collapse (certainly the most characteristic and most severe side effect) because the drug is programmed to obtain. Possible corrective or preventive interventions may in some cases even be left to the discretion of the operator.
第3の手順は、患者体内に確認される特定信号を計算に
入゛れて、透析治療を実施するに当たっての準備を整え
ることである。このような手順は、透析分野の研究主題
であるが、しかしながら、患者の状態に関する限りの確
実な基本的生理値を識別しかつ測定するに当たり存在す
る困難の、文は、とりわけ、このような値に相当する信
号を処理しかつ利用するための効果的戦略を規定するに
当たり存在する困難のどちらかのために、未だ充分に具
体化されるに至ってはいない。The third step is to take into account the specific signals identified within the patient's body in preparation for performing the dialysis treatment. Such procedures are the subject of research in the field of dialysis, however, due to the difficulties that exist in identifying and measuring reliably basic physiological values as far as the patient's condition is concerned, statements such as has not yet been fully specified, either due to the difficulties that exist in defining effective strategies for processing and utilizing signals corresponding to .
[問題を解決するための手段]
本発明の目的は、オペレータに好機に介入可能とさせ及
び(又は) Fa1作用の起こるのを防止する手順を自
動的に作動させるように、透析治療を受けている患者に
副作用の発現自体の起こるのを高信頼性を以て予測する
ことのできる装置を提供することにある。SUMMARY OF THE INVENTION It is an object of the present invention to enable operators to intervene opportunistically and/or to automatically activate procedures that prevent Fa1 effects from occurring. An object of the present invention is to provide a device that can predict with high reliability the occurrence of side effects in a patient.
この目的は、透析治療中に患者体内の副作用発現自体の
予測装置に関する本発明によって実現される。この装置
は、次の特徴を含む。This object is achieved by the present invention, which relates to a device for predicting the occurrence of side effects within a patient's body during dialysis treatment. This device includes the following features:
患者の少なくとも1つの血流力学値を測定する血流測定
装置であって、時間に対するこの血流力学値の変動に相
当する少なくとも1つパラメータを与える能力のあるこ
の血流測定装置、所定期間に関してこのパラメータ、す
なわち、信号の平均変動に相当する少なくとも1つの定
格(ratino)を計算する信号処理装置、この定格
に対して得られた値を安全値の範囲を定める少なくとも
1つの参照値と比較する比較装置、
この定格に対して得られた値が参照値によって定められ
た安全値の範囲から逸脱する度にtill @信号とし
て利用されることのできる警報信号を発射する警報装置
。A blood flow measuring device for measuring at least one hemodynamic value of a patient, said blood flow measuring device capable of providing at least one parameter corresponding to the variation of this hemodynamic value over time, with respect to a predetermined period of time. A signal processing device that calculates this parameter, i.e. at least one rating (ratino) corresponding to the average variation of the signal, and compares the value obtained for this rating with at least one reference value that defines a range of safe values. Comparison device, an alarm device which emits an alarm signal which can be used as a till @ signal whenever the value obtained for this rating deviates from the safe value range defined by the reference value.
[実施例]
本発明をさらに容易に理解してもらうために、好適実施
例について、純粋に非限定的な例として、付図を参照し
て以下に説明する。BRIEF DESCRIPTION OF THE DRAWINGS In order to make the invention easier to understand, preferred embodiments are described below, purely by way of non-limiting example, with reference to the accompanying drawings.
第1図を参照すると、周知の形式の透析器械3により行
われる透析治療中に患者2体内に副作用自体が発現する
おそれがあるが、予測装置1は、透析治療中の患者体内
の副作用発現自体を予測する。Referring to FIG. 1, there is a possibility that side effects will occur in the body of a patient 2 during dialysis treatment performed using a dialysis machine 3 of a well-known type. Predict.
本発明によれば、予測装置1は、基本的に次を含む。According to the invention, the prediction device 1 basically includes the following:
患者の血流力学値を測定する能力があり、かつ時間に対
してこの血流力学値自体の変動に相当するパラメータを
供給する能力のあるセンサ5、センサ5から到来する信
号を処理し、所定期間に関して上述のパラメータの変動
に相当する少な(とも1つの定格を計算する信号処理装
置6、上述の定格に対して得られた値を安全値の所定範
囲を定める少なくとも1つの参照値と比較する比較装置
7、
信号処理装置6によって計算された上述の定格に対して
得られた値がこの参照値によって定められた安全値の範
囲を超える度にIll III信号として使用されるこ
とのできる警報信号を発射する警報装置9、
以下の詳細な説明は、測定された血流力学値が、例えば
、心拍数であると仮定する。A sensor 5 capable of measuring the hemodynamic value of the patient and supplying a parameter corresponding to the variation of this hemodynamic value itself over time, processing the signal coming from the sensor 5 and a signal processing device 6 which calculates a rating corresponding to the variation of the above-mentioned parameter with respect to a period, and compares the value obtained for the above-mentioned rating with at least one reference value defining a predetermined range of safe values; a comparator 7, an alarm signal which can be used as an Ill III signal whenever the value obtained for the above-mentioned rating calculated by the signal processing device 6 exceeds the range of safe values defined by this reference value; The following detailed description assumes that the measured hemodynamic value is, for example, heart rate.
このような考察の観点から、センサ5は、例えば、簡単
な周波数計を含み、これらの出力の1つは処理装置6の
一部を形成する低域通過ディジタルフィルタ11に接続
される。In view of this consideration, the sensor 5 includes, for example, a simple frequency meter, one of whose outputs is connected to a low-pass digital filter 11 forming part of the processing device 6 .
このフィルタの基本的な機能は、雑音を除去する結果、
センサ5によって発射された生理的信号のみをこの信号
自体の帯域内で通過させることにある。The basic function of this filter is to remove noise,
The purpose is to pass only the physiological signal emitted by the sensor 5 within the band of this signal itself.
この信号処理装置6は、1つの記憶素子から記憶素子へ
と桁送りする記憶装置12を含む。説明する場合におい
ては、この記憶装置は、例えば、3つの同等の記憶素子
13,14.15を含み、これらのうちの最初の素子1
3はフィルタ11の出力に接続される。This signal processing device 6 includes a storage device 12 that shifts from one storage element to another. In the case described, this storage device includes, for example, three equivalent storage elements 13, 14, 15, of which the first element 1
3 is connected to the output of filter 11.
信号処理装置6は、さらに、計算装置17を含み、後者
の備える3つの信号入力はそれぞれ記憶装置12の記憶
素子13,14.15の出力に互いに並列に接続され、
及び正規化装置118は計算装置17の出力に接続され
る入力と比較装置7の入力に接続される出力を有する。The signal processing device 6 further includes a calculation device 17, the three signal inputs of the latter being connected in parallel to each other to the outputs of the storage elements 13, 14, 15 of the storage device 12,
and normalization device 118 has an input connected to the output of calculation device 17 and an output connected to the input of comparison device 7.
計算装!t17は、例えば、この場合、y軸上の3つの
値(記憶素子13,14.15内に記憶された値)を考
慮することによって得られる線分(第3a図参璽)の係
数又は勾配“ai”及びah bHuを計算する観点か
ら最小二乗線形回帰を実施する能力を備える。Calculator! t17 is, for example, the coefficient or slope of the line segment (see Fig. 3a), which in this case is obtained by considering the three values on the y-axis (values stored in storage elements 13, 14, 15). Provides the ability to perform least squares linear regression in terms of calculating “ai” and ah bHu.
正規化装置!18の唯一の目的は、各線分の“al”に
対して、−1と+1の間にある相当値“a I i
J+を、例えば、次式を適用することによって計算する
ことにある。Normalization device! The sole purpose of 18 is that for each line segment “al”, the equivalent value “a I i
The purpose is to calculate J+, for example, by applying the following equation.
信号装置6は、最終的に管理モジュロ20を与えられ、
例えば、マイクロプロセッサを含み、このマイクロプロ
セッサは構成要素間の信号を統制する観点から、記憶装
置21及び玉揚の全ての構成要素(フィルタ11、記憶
装置12及び計算装置17及び正規化装[18)に接続
される。信号処理装置6を、便利上、マイクロプロセッ
サによって構成することができる。The signaling device 6 is finally given a management modulo 20,
For example, it includes a microprocessor that controls the storage device 21 and all the components of the doffing device (the filter 11, the storage device 12 and the calculation device 17 and the normalization device [18]) from the point of view of regulating the signals between the components. connected to. The signal processing device 6 may conveniently be constituted by a microprocessor.
比較装置7は、従来式のものであり、したがって、この
比較装置は、一対のしきい値比較器24゜25を含みこ
れらの各々は処理装置6(この場合、正規化装置18)
の出力に接続される第1出力及びそれぞれ滑動接点26
.27によりポテンショメータ28.29に接続される
第2人力を有する。The comparator device 7 is of the conventional type and thus comprises a pair of threshold comparators 24, 25, each of which is connected to a processing device 6 (in this case a normalizer 18).
a first output connected to the output of and each sliding contact 26
.. 27 has a second human power connected to the potentiometer 28.29.
ポテンショメータ28.29は、直列接続され、かつこ
れらのそれぞれ反対側の端子を端子31゜32に接続さ
れこれに直流電源の正極及び負極がそれぞれ(図には示
されていない方法で)接続される。The potentiometers 28 and 29 are connected in series, and their respective opposite terminals are connected to terminals 31 and 32, to which the positive and negative poles of the DC power supply are respectively connected (in a manner not shown). .
しきい値比較器24.25は、次のように配設される、
すなわち、それぞれの出力に現れる信号は、これらの第
1人力に現れる信号が滑動接点26.27によって取り
上げられる参照電圧値間内にあるまでは“0″論理レベ
ルにあり、一方、第2人力に現れる信号が上述の参照信
号値よりそれぞれ高くなる又は低(なる度に“1”論理
レベルに移行する。The threshold comparators 24.25 are arranged as follows:
That is, the signals appearing at the respective outputs are at a "0" logic level until the signals appearing at these first inputs are within the reference voltage values picked up by the sliding contacts 26,27, while at the second output. Each time the appearing signal becomes higher or lower (respectively) than the above-mentioned reference signal value, it transitions to a "1" logic level.
制御信号として利用されることのできる警報信号を発射
する警報装置9は、単にOR式論理ゲート34を含み、
その2つの入口はそれぞれ上流側の比較器24′、25
の出力に接続され、下流側を増幅装置35に接続される
。The alarm device 9, which emits an alarm signal that can be used as a control signal, simply comprises an OR logic gate 34;
The two inlets are connected to the upstream comparators 24' and 25, respectively.
The downstream side is connected to the amplifier 35.
増幅装置35の出力は、端子36並びに、通常、音響警
報器39と警報ランプ39を含む警報器37に接続され
る。The output of the amplifier 35 is connected to a terminal 36 and an alarm 37, which typically includes an audible alarm 39 and an alarm lamp 39.
低域通過フィルタ11の出力は端子118$1へ通じ、
かつ正規化装W118の出力は端子“b”へ通じる。さ
らに患者2は、動脈血圧センサ40へ接続され、後者の
出力は端子“C”へ通じる。The output of low-pass filter 11 passes to terminal 118$1;
And the output of normalizer W118 is connected to terminal "b". Furthermore, the patient 2 is connected to an arterial blood pressure sensor 40, the output of the latter leading to terminal "C".
第2a図、第2b図、第2C図において、分の単位で表
示される時間に基づいて上述の端子“a”b”C″から
出力される電気信号の運動が、それぞれ、Va、Vb、
Vcで表示されている。2a, 2b, and 2C, the motion of the electrical signals outputted from the terminals "a", "b", and "C" based on the time expressed in minutes is Va, Vb, respectively.
It is displayed as Vc.
第2b図において、V26及びV27は、ポテンショメ
ータ28.29の滑動接点26.27によって、同時に
取り上げられるそれぞれしきい電圧の2つの相当値を表
示する。In FIG. 2b, V26 and V27 represent two corresponding values of the respective threshold voltages taken up simultaneously by sliding contacts 26.27 of potentiometers 28.29.
第3a図は、上述の手順に従う線形回帰によって得られ
る線分の勾配に相当する複数の係数ai(第3b図)を
初期的に得るように信@Va<第3a図)を数学的に処
理する2つの例、及び第3b図の表示に従いこれらの係
数から得られた値の−1と+1との間の、逐次、正規化
を示す。最終的に、本発明により提案される方法は、こ
の特定の場合における次の逐次操作の実行に対する準備
を整える。すなわち、
患者2の心拍数を測定すること、
所定期間に関するこのような心拍数の変動に相関する少
なくとも1つの規格を得るように測定心拍数信号を処理
すること、
上述の規格に対して得られたこの値を安全値の範囲を定
める少なくとも1つの値と比較すること、計算された規
格に対して得られたこの値が上述の参照値によって定め
られた安全値の範囲の外に移動する廉に制御信号として
利用されることのできる警報信号を発射すること。Figure 3a shows the mathematical processing of the belief @Va<Figure 3a) to initially obtain a plurality of coefficients ai (Figure 3b) corresponding to the slope of the line segment obtained by linear regression according to the procedure described above. 3b and the successive normalization between -1 and +1 of the values obtained from these coefficients according to the representation in FIG. 3b. Finally, the method proposed by the invention prepares for the execution of the next sequential operation in this particular case. namely: measuring the heart rate of the patient 2; processing the measured heart rate signal so as to obtain at least one standard correlating to the variation of such heart rate over a predetermined period; Comparing the value of the octopus with at least one value defining a range of safe values, and checking whether this value obtained for the calculated standard moves outside the range of safe values defined by the reference values mentioned above. To emit an alarm signal that can be used as a control signal.
一般的に、心拍数に比例する信号は、センサ5により検
出されて、低域フィルタ11内で処理され、次いで各都
度に目盛り付は記憶装置12内に3つの値の群に記憶さ
れる。In general, a signal proportional to the heart rate is detected by the sensor 5 and processed in a low-pass filter 11, and then in each case the graduation is stored in groups of three values in the memory 12.
例えば、最初の3つの測定心拍数値f1.f2゜f3(
第3a図)が記憶装置12の記憶素子13゜14.15
内にそれぞれ記憶され、後続の値f4が素子13を占領
して値f3及びf2の素子15及び14への桁送りを起
こさせ、かつ値f1を外へ追い出し、以後同様に繰り返
される。For example, the first three measured heart rate values f1. f2゜f3(
3a) is the memory element 13°14.15 of the memory device 12.
The subsequent value f4 occupies element 13 causing the values f3 and f2 to be shifted into elements 15 and 14, and pushes the value f1 out, and so on.
記憶装置12内に記憶された3つの心拍数の各群ごとに
、計算装置117は、上述の指定に従って線形回帰を行
い、これによってfl、f2.f3を計算に入れて得ら
れた相当する線分の係数”ai”及び“b1″を決定し
、次にf2.f3゜f4を計算に入れて得られた相当す
る線分の係数11821%及び“b2”を決定し、以下
同様に繰り返す。For each group of three heart rates stored in the storage device 12, the computing device 117 performs a linear regression according to the above specifications, thereby determining fl, f2 . Determine the coefficients "ai" and "b1" of the corresponding line segment obtained by taking f3 into the calculation, and then f2. The coefficients 11821% and "b2" of the corresponding line segment obtained by taking f3° f4 into the calculation are determined, and the same procedure is repeated.
このようにして、係数“ai″の順序が得られ(第3b
図参照)これは計算装置17の出力から供給され、この
順序は、全体として、センサ5によって検出されかつフ
ィルタ11によって処理された心拍数信号の勾配を表示
する。In this way, the order of the coefficients “ai” is obtained (3rd b
(See figure) This is fed from the output of the computing device 17 and this sequence overall represents the slope of the heart rate signal detected by the sensor 5 and processed by the filter 11.
正規化装置18内で行われる次の操作は、上に指定され
たように、振幅が−1と+1との間にある相当値“a′
i”を得るように上述の係数゛ai”を調整すること
にある。検査を構成する次の段は、相当値”a′ i”
の各々が2つのそれぞれしきい値V27とV28によっ
て上限と下限を定められた安全値の範囲内に存在するか
どうかの判定を可能にする。この操作は、比較器ff1
7において比較器24.25及びポテンショメータ28
及び29によって実行される。The next operation carried out within the normalizer 18 is to select the equivalent value "a' whose amplitude is between -1 and +1, as specified above.
The purpose is to adjust the above-mentioned coefficient ``ai'' so as to obtain ``i''. The next step that constitutes the test is the equivalent value “a′ i”
makes it possible to determine whether each of the values lies within a range of safe values bounded by two respective thresholds V27 and V28. This operation is performed using the comparator ff1
Comparator 24.25 and potentiometer 28 at 7
and 29.
確立された限界から係数゛a(”の1つが逸脱するよう
な場合(例えば、第3C図の値“al i4”参照)は
、比較器24及び25が、“1′論理レしル信号をOR
ゲート34の対応する入力に送り、それぞれの論理信号
出力の“0″から“1”へのスイッチングを及びそれに
続いての制御信号の増幅装置35からの発射を起こさせ
る。In the event that one of the coefficients "a(") deviates from the established limits (see, for example, the value "al i4" in FIG. OR
to the corresponding inputs of the gates 34 to cause the switching of the respective logic signal output from "0" to "1" and the subsequent firing of the control signal from the amplifier device 35.
制御信号のこの発射は音響警報器38及び警報ランプ3
9の動作、並びに電気信号の端子36への発射を開始さ
せ、この電気信号はその後の使用、例えば、透析′器械
3によって実施されている透析の特定のパラメータを自
動的に変調することに利用される。This emission of the control signal causes the audible alarm 38 and the alarm lamp 3
9 and the firing of an electrical signal to the terminal 36, which electrical signal is utilized for subsequent use, for example to automatically modulate certain parameters of the dialysis being carried out by the dialysis machine 3. be done.
第2図は1つの臨床実例に圓し、そこでは“心拍数″血
流力学値が各10鼓動ごとに測定され、従来式にディジ
タル帯域通過フィルタによってフィルタ処理され、及び
“正規化勾配”が15個の試料に渡る輪形回帰によって
得られる(この場合、桁おくり記憶装置F12は15個
の記憶素子を含む)。Figure 2 depicts a clinical example in which "heart rate" hemodynamic values are measured every 10 beats, conventionally filtered by a digital bandpass filter, and "normalized gradient" It is obtained by circular regression over 15 samples (in this case, the digit-shifting memory F12 includes 15 memory elements).
この図を詳細に観察すると、次のことが解るであろう、
すなわち、安全値の範囲の下限しきい値V27を超えて
降下する出力信号vbが(約7分程度の)時限下の開始
時刻t1に発生され、この時限のn端時刻t2に一致し
て患者の動脈血圧に突然の低下が見られ、これが患者の
心臓−循環器系虚説を生じる。If you look at this diagram in detail, you will find the following:
That is, an output signal vb falling above the lower threshold value V27 of the safe value range is generated at the lower start time t1 of the time limit (about 7 minutes or so), and coincident with the n-terminal time t2 of this time limit, the output signal vb is There is a sudden drop in arterial blood pressure, which causes the patient to have a cardiac-circulatory system deficiency.
第2図に報告されたような、臨床実例を調べると、本発
明によって提供される予測装置を使って得られる予測動
作の重要性が明確に立証されていることが認められるで
あろう。It will be appreciated that an examination of clinical examples, such as those reported in FIG. 2, clearly demonstrates the importance of predictive behavior obtained using the predictive device provided by the present invention.
事実、巽常の連絡は時刻t1になされ、一方、心拍数の
実効値(約61心拍/分)及び平均動脈血圧(約83履
11(1)は、透析を受けている患者にとっては正常値
内に完全に納まるとなお考えることができる。このこと
は、これらの値を測定することのできる器械によって与
えられる瞬間的データの分析は、本発明が達成しようと
している目的にとって不適当であることの証明を、示し
ている。In fact, Tatsumi's communication was made at time t1, while the effective value of heart rate (approximately 61 beats/min) and mean arterial blood pressure (approximately 83 beats/min) are normal values for a patient undergoing dialysis. This means that the analysis of the instantaneous data provided by instruments capable of measuring these values is inappropriate for the purpose that the present invention seeks to achieve. shows the proof of.
本発明による予測装置の特性を調べると、次のようなま
ぎれもない利点が明らかになる。An examination of the characteristics of the prediction device according to the invention reveals the following undeniable advantages.
第1に、臨界生理的状況についての有効かつ、とりわけ
、充分に早期に与えられる表示が得られる。このことは
、早めに対策を加えることを可能とし、したがって、患
者が心臓−循環器系虚説に見舞われるのをまたこの状況
に伴うあらゆる後遺症(なかでも、患者から心臓病)を
予防する。Firstly, an effective and, above all, sufficiently early indication of the critical physiological situation is obtained. This allows early intervention and thus prevents the patient from suffering from cardio-circulatory system deception and all the sequelae associated with this situation (among others, heart disease from the patient).
この予測装置によって供給されるデータを早めに利用す
ることによって、例えば、透析器械3を使って操作され
る透析手順において、オペレータにとって起こり得る緊
急態勢を単に信号表示することによって、担当技術者は
、自動的、時機を得た、かつ充分な介入のための準備を
整えることができる。By early use of the data provided by this predictive device, for example in a dialysis procedure operated using the dialysis machine 3, by simply signaling a possible emergency situation to the operator, the technician in charge can: Provisions can be made for automatic, timely and sufficient intervention.
最後に、上述の予測装置11にとって本発明の範囲から
逸脱することなく修正及び変更を導入できることは明ら
かである。Finally, it is clear that modifications and changes can be introduced to the prediction device 11 described above without departing from the scope of the invention.
なかでも、もし−組の規格が作成されるならば、信号の
分析は遥かに複雑になり、これらの規格の各々が少なく
とも1つの相当するしきい値と比較されなければならな
い。Among other things, the analysis of the signal becomes much more complex if a set of standards is created, each of these standards having to be compared with at least one corresponding threshold.
遥かに簡単に、回帰試料の数、すなわち、桁送り記憶装
置の記憶素子の数を1つの時限から他の時限へと又は信
号の特性に従って動的に変動させ4゜
ることもできる。Much more simply, the number of regression samples, ie the number of storage elements of the shift storage device, can also be varied dynamically by 4 degrees from one time period to another or according to the characteristics of the signal.
さらに、被測定値として心拍数が選択されたけれども、
この血流力学値と時間的に関連している、他の血流力学
値を測定することもでき、これらの1つまたはいくつか
のオペレータ(振幅、心拍数、等々)を選択することも
考えられる。例として、心拍振幅信号及び心電計信号に
ついての測定と計算は、非侵入性心拍娠幅測定装置及び
従来式の心電図監視装置を適切に使用することによって
実施することができる。Furthermore, although heart rate was selected as the measured value,
It is also possible to measure other hemodynamic values that are temporally related to this hemodynamic value and consider selecting one or several operators of these (amplitude, heart rate, etc.). It will be done. By way of example, measurements and calculations for heartbeat amplitude signals and electrocardiogram signals can be performed by appropriate use of non-invasive heartbeat amplitude measurement devices and conventional electrocardiogram monitoring devices.
第1図は、本発明による透析治療患者体内副作用予測装
置の機能ブロック線図、
第2図は、特定の臨床例における第1図のブロック線図
の点a、b、及びCにおいてそれぞれ取り出された3つ
の信号に時間的に対応させて並べた波形図、
第2図aは、この特定臨床例におけるフィルタ処理後の
心拍数の時間に対する波形図、第2図すは、逐次線分の
勾配“ai”を、心拍数についての−1と+1の間にあ
る正規化単位により計算して正規化した相当値の時間に
対する波形図、
第2図Cは、平均血圧値の時間に対する波形図、第3図
は、第1図のブロック線図で示された予測装置によって
実施される信号処理の例を説明するグラフ図、である。
[記号の説明]
1:透析治療中の患者体内の副作用自体の予測装置
2:患者
3:透析器械
5:センサ
6:信号処理装置
7:比較装置
9:警報装置
11:フィルタ
12:桁送り記憶装置
17:計算装置
18:正規化装置
20 :
21 :
24゜
28゜
35 :
管理モジュロ
記憶装置
25:しきい値比較器
29:ポテンショメータ
増幅装置FIG. 1 is a functional block diagram of the in-vivo side effect prediction device for dialysis treatment patients according to the present invention, and FIG. Figure 2a is a waveform diagram of the three signals arranged in temporal correspondence. Figure 2a is a waveform diagram of the heart rate versus time after filtering in this specific clinical case. Figure 2a is a diagram showing the slope of the sequential line segment. A waveform diagram of the equivalent value obtained by calculating and normalizing “ai” using a normalization unit between −1 and +1 for the heart rate over time; FIG. 2C is a waveform diagram of the average blood pressure value over time; FIG. 3 is a graph diagram illustrating an example of signal processing performed by the prediction device shown in the block diagram of FIG. 1. [Explanation of symbols] 1: Device for predicting side effects in the patient's body during dialysis treatment 2: Patient 3: Dialysis machine 5: Sensor 6: Signal processing device 7: Comparison device 9: Alarm device 11: Filter 12: Digit storage Device 17: Calculation device 18: Normalization device 20: 21: 24°28°35: Management modulo storage device 25: Threshold comparator 29: Potentiometer amplifier device
Claims (1)
置であつて、 患者の少なくとも1つの血流力学値を測定する血流測定
装置であつて、時間に対する前記血流力学値の変動に相
当する少なくとも1つパラメータを与える能力のある前
記血流測定装置と、 所定期間に関して前記パラメータの平均変動に相当する
少なくとも1つの定格を計算する信号処置装置と、 前記定格に対して得られた値を安全値の範囲を定める少
なくとも1つの参照値と比較する比較装置と、 前記定格に対して得られた値が前記参照値によつて定め
られた安全値の範囲から逸脱する度に制御信号として利
用されることのできる警報信号を発射する警報装置と、 を包含することを特徴とする前記予測装置。 (2)請求項1記載の予測装置において、前記血流測定
装置は、心拍数、心電計信号、及び(又は)心拍振幅の
測定機器の少なくとも1つを含むことを特徴とする前記
予測装置。(3)請求項1又は2に記載の予測装置にお
いて、前記信号処理装置は前記血流測定装置の下流に配
置されたフィルタを含むことを特徴とする前記予測装置
。 (4)請求項1から3のうちいずれか1つに記載の予測
装置において、前記信号処理装置は、動作中、前記血流
測定装置によつて供給される前記信号を記憶する記憶装
置及び前記定格を計算する計算装置とを含むことを特徴
とする前記予測装置。 (5)請求項1から4のうちいずれか1つに記載の予測
装置において、前記処理装置はマイクロプロセッサを含
むことを特徴とする前記予測装置。 (6)請求項1から5のうちいずれか1つに記載の予測
装置において、前記比較装置は少なくとも1つのしきい
値比較器を含むことを特徴とする前記予測装置。 (7)請求項6記載の予測装置において、前記比較装置
は前記しきい値比較器のしきい値を調整する少なくとも
1つの調整要素を含むことを特徴とする前記予測装置。 (8)請求項1から7のうちいずれか1つに記載の予測
装置であつて、前記警報を発射するために前記警報装置
によつて駆動される異常を信号表示する信号装置を含む
ことを特徴とする前記予測装置。 (9)請求項8記載の予測装置において、前記信号装置
は音響式のもの及び(又は)光学式のものであることを
特徴とする前記予測装置。 (10)請求項1から9のうちいずれか1つに記載の予
測装置であつて、前記患者に動作中接続されることがで
きかつ前記警報装置によつて制御される制御装置を含む
ことを特徴とする前記予測装置。[Scope of Claims] (1) A blood flow measuring device that measures at least one hemodynamic value of a patient, the device for predicting side effects occurring in a patient's body during dialysis treatment, said blood flow measuring device capable of providing at least one parameter corresponding to a variation in a hydrodynamic value; a signal processing device capable of calculating at least one rating corresponding to an average variation of said parameter over a predetermined period of time; a comparison device for comparing the value obtained for said rating with at least one reference value defining a range of safe values; and the value obtained for said rating deviates from the range of safe values defined by said reference value. and an alarm device that emits an alarm signal that can be used as a control signal each time a prediction occurs. (2) The prediction device according to claim 1, wherein the blood flow measurement device includes at least one of a heart rate, an electrocardiograph signal, and/or a heartbeat amplitude measurement device. . (3) The prediction device according to claim 1 or 2, wherein the signal processing device includes a filter disposed downstream of the blood flow measuring device. (4) In the prediction device according to any one of claims 1 to 3, during operation, the signal processing device includes a storage device that stores the signal supplied by the blood flow measuring device; and a calculation device that calculates a rating. (5) The prediction device according to any one of claims 1 to 4, wherein the processing device includes a microprocessor. (6) The prediction device according to any one of claims 1 to 5, wherein the comparison device includes at least one threshold comparator. (7) The prediction device according to claim 6, wherein the comparison device includes at least one adjustment element that adjusts the threshold value of the threshold comparator. (8) The prediction device according to any one of claims 1 to 7, further comprising a signaling device that signals an abnormality that is driven by the warning device to issue the warning. The prediction device characterized by: (9) The prediction device according to claim 8, wherein the signal device is an acoustic type and/or an optical type. (10) The prediction device according to any one of claims 1 to 9, comprising a control device that can be operatively connected to the patient and is controlled by the alarm device. The prediction device characterized by:
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT67564/88A IT1219379B (en) | 1988-06-15 | 1988-06-15 | METHOD AND EQUIPMENT FOR THE PREDICTION OF THE SIDE EFFECTS WHICH MANIFEST IN A PATIENT DURING A DIALYSIS TREATMENT |
| IT67564A/88 | 1988-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0284932A true JPH0284932A (en) | 1990-03-26 |
Family
ID=11303474
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1152015A Pending JPH0284932A (en) | 1988-06-15 | 1989-06-14 | Apparatus for estimating manifestation itself of side effect in patient during dialytic treatment |
| JP005178U Pending JPH11154U (en) | 1988-06-15 | 1999-07-12 | A device for predicting the occurrence of side effects in patients during dialysis treatment |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP005178U Pending JPH11154U (en) | 1988-06-15 | 1999-07-12 | A device for predicting the occurrence of side effects in patients during dialysis treatment |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4967754A (en) |
| EP (1) | EP0347345B2 (en) |
| JP (2) | JPH0284932A (en) |
| DE (1) | DE68918167T3 (en) |
| ES (1) | ES2058584T5 (en) |
| IT (1) | IT1219379B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014117537A (en) * | 2012-12-18 | 2014-06-30 | Fujitsu Ltd | Waveform detecting device, waveform detecting method, and waveform detecting program |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5098560U (en) * | 1974-01-11 | 1975-08-16 | ||
| US5230702A (en) * | 1991-01-16 | 1993-07-27 | Paradigm Biotechnologies Partnership | Hemodialysis method |
| IT1252601B (en) * | 1991-07-05 | 1995-06-19 | Hospal Dasco Spa | EQUIPMENT AND AUTOMATIC DIALYSIS METHOD |
| FR2693110B1 (en) * | 1992-07-06 | 1994-08-19 | Hospal Ind | Method for verifying the operation of sensors located on a dialysis liquid circuit and device using it. |
| FI931234A7 (en) * | 1993-03-19 | 1994-09-20 | Instr Oy | Method for monitoring patient condition |
| AU1126897A (en) * | 1995-11-28 | 1997-06-19 | Anthony Joseph | System for evaluating treatment of chest pain patients |
| FR2794353B1 (en) * | 1999-06-01 | 2001-10-19 | Joel Mercier | METHOD AND DEVICE FOR MONITORING THE VALUE OF PHYSIOLOGICAL PARAMETERS |
| US7428301B1 (en) | 2000-10-09 | 2008-09-23 | Clawson Jeffrey J | Method and system for the exit protocol of an emergency medical dispatch system |
| DE10114383B4 (en) * | 2001-03-23 | 2010-09-23 | Fresenius Medical Care Deutschland Gmbh | Blood pressure device and device for extracorporeal blood treatment with such a blood monitoring device |
| US8417533B2 (en) | 2001-09-25 | 2013-04-09 | Jeffrey J. Clawson | Method and system for the fire response dispatch protocol of an emergency dispatch system |
| US7436937B2 (en) | 2001-09-26 | 2008-10-14 | Clawson Jeffrey J | Method and system for the police response dispatch protocol of an emergency dispatch system |
| DE10157653B4 (en) * | 2001-11-26 | 2005-01-27 | Pe Diagnostik Gmbh | A method for predicting a summary rating of a person's parameters |
| US8494868B2 (en) | 2002-05-07 | 2013-07-23 | Priority Dispatch Corporation | Method and system for a seamless interface between an emergency medical dispatch system and a nurse triage system |
| JP3958733B2 (en) * | 2002-11-14 | 2007-08-15 | 日機装株式会社 | Blood purification equipment |
| US8060190B2 (en) | 2004-09-13 | 2011-11-15 | Gambro Lundia Ab | Detection of drastic blood pressure changes |
| JP4094600B2 (en) * | 2004-10-06 | 2008-06-04 | 日機装株式会社 | Blood purification equipment |
| US8066638B2 (en) | 2007-06-13 | 2011-11-29 | Clawson Jeffrey J | Diagnostic and intervention tools for emergency medical dispatch |
| US7645234B2 (en) | 2007-06-13 | 2010-01-12 | Clawson Jeffrey J | Diagnostic and intervention tools for emergency medical dispatch |
| WO2010033314A1 (en) * | 2008-09-19 | 2010-03-25 | Cardiac Pacemakers, Inc. | Central venous pressure sensor and method to control a fluid or volume overload therapy |
| DE102008061122A1 (en) * | 2008-12-09 | 2010-06-17 | Fresenius Medical Care Deutschland Gmbh | Method and device for determining and / or monitoring a physical condition, in particular a cardiovascular size, of a patient based on an amplitude of a pressure signal |
| US8971501B2 (en) * | 2009-04-13 | 2015-03-03 | Priority Dispatch Corporation | Methods and systems to identify code hierarchy bias in medical priority dispatch systems |
| US8355483B2 (en) | 2009-09-11 | 2013-01-15 | Clawson Jeffrey J | Stroke diagnostic and intervention tool for emergency dispatch |
| US8335298B2 (en) | 2009-09-14 | 2012-12-18 | Clawson Jeffrey J | Pandemic diagnostic and intervention tool for emergency dispatch |
| US8294570B2 (en) | 2010-02-24 | 2012-10-23 | Clawson Jeffrey J | Burn diagnostic and intervention tool for emergency dispatch |
| US8582866B2 (en) | 2011-02-10 | 2013-11-12 | Edge 3 Technologies, Inc. | Method and apparatus for disparity computation in stereo images |
| SG10201600390TA (en) | 2011-01-19 | 2016-02-26 | Jeffrey J Clawson | Meningitis Diagnostic And Intervention Tool For Emergency Dispatch |
| US8396191B2 (en) | 2011-02-11 | 2013-03-12 | Jeffrey J. Clawson | Anti-social protocol for emergency dispatch |
| US8670526B2 (en) | 2011-02-11 | 2014-03-11 | Jeffrey J. Clawson | Hate crime diagnostic and intervention tool for emergency dispatch |
| US8712020B2 (en) | 2012-09-06 | 2014-04-29 | Jeffrey J. Clawson | Pandemic protocol for emergency dispatch |
| US8873719B2 (en) | 2013-01-31 | 2014-10-28 | Jeffrey J. Clawson | Active assailant protocol for emergency dispatch |
| BR112015017411B1 (en) | 2013-01-31 | 2022-09-27 | Jeffrey J. Clawson | METHOD AND SYSTEM FOR GUIDING A DISPATCH WHEN COMMUNICATING WITH A PERSON NEEDING ASSISTANCE THROUGH A COMMUNICATION DEVICE REGARDING AN EMERGENCY OCCURRENCE, AND COMPUTER-READABLE NON-TRANSITORY STORAGE MEDIA |
| CA2971232C (en) * | 2014-12-17 | 2023-02-28 | Newsol Technologies Inc. | System and method for peritoneal dialysis |
| US10842926B2 (en) * | 2015-01-14 | 2020-11-24 | Fresenius Medical Care Deutschland Gmbh | Medical fluid treatment machines and related systems and methods |
| US9516166B1 (en) | 2015-05-28 | 2016-12-06 | Jeffrey J. Clawson | Chemical suicide protocol for emergency response |
| US10657614B2 (en) | 2015-12-23 | 2020-05-19 | Jeffrey J. Clawson | Locator diagnostic system for emergency dispatch |
| US12214113B2 (en) | 2016-02-01 | 2025-02-04 | Liberdi Ltd. | Dialysis system pump with connector |
| WO2018142406A1 (en) | 2017-02-01 | 2018-08-09 | Liberdi Ltd. | Smart peritoneal dialysis device |
| US9877171B2 (en) | 2016-04-08 | 2018-01-23 | Jeffrey J. Clawson | Picture/video messaging protocol for emergency response |
| AU2019256700A1 (en) | 2018-04-19 | 2020-11-26 | Jeffrey Clawson | Expedited dispatch protocol system and method |
| IL278995B (en) * | 2020-11-25 | 2022-07-01 | Liberdi Ltd | System, method and computer-implemented platform for providing patient-related information |
| US11910471B2 (en) | 2021-04-23 | 2024-02-20 | Priority Dispatch Corp. | System and method for emergency dispatch |
| US11937160B2 (en) | 2021-04-23 | 2024-03-19 | Priority Dispatch Corporation | System and method for emergency dispatch |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5143881A (en) * | 1974-07-19 | 1976-04-14 | Medicor Muevek | TOKUNIJUSHOKANJANOSHUCHUKANSHINIMOCHIIRUKIKENYOTAININSHIKYOHOHO OYOBI SOCHI |
| JPS5151192A (en) * | 1974-10-29 | 1976-05-06 | Tokyo Shibaura Electric Co | |
| JPS57150944A (en) * | 1981-03-13 | 1982-09-17 | Nippon Koden Kogyo Kk | Monitor and alarm apparatus for cardiac pulses |
| JPS6092769A (en) * | 1983-10-27 | 1985-05-24 | 株式会社メデクス | Apparatus for treating blood in outside of living body |
| JPH01126978A (en) * | 1987-10-30 | 1989-05-19 | Henry Ford Hospital | Automated method for controlling dialysis of blood according to blood pressure and heart rate of patient |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1370943A (en) * | 1971-03-18 | 1974-10-16 | Nat Res Dev | Tatient monitoring systems |
| US4098274A (en) * | 1976-10-18 | 1978-07-04 | Baxter Travenol Laboratories, Inc. | Digital memory with power outage and memory overload logic in a dialysis system |
| IT1131177B (en) * | 1980-05-14 | 1986-06-18 | Consiglio Nazionale Ricerche | PROGRAMMABLE BAND COMPARATOR, MULTI-CHANNEL, FOR CARDIOSURGICAL UNITS |
| JPS58216031A (en) * | 1982-06-09 | 1983-12-15 | シャープ株式会社 | Pulse measuring apparatus |
| US4710164A (en) * | 1984-05-01 | 1987-12-01 | Henry Ford Hospital | Automated hemodialysis control based upon patient blood pressure and heart rate |
| US4718891A (en) * | 1984-05-03 | 1988-01-12 | Henry Ford Hospital | Automated hemodialysis control based upon patient blood pressure and heart rate |
-
1988
- 1988-06-15 IT IT67564/88A patent/IT1219379B/en active
-
1989
- 1989-06-12 US US07/364,292 patent/US4967754A/en not_active Expired - Lifetime
- 1989-06-13 ES ES89420209T patent/ES2058584T5/en not_active Expired - Lifetime
- 1989-06-13 DE DE68918167T patent/DE68918167T3/en not_active Expired - Lifetime
- 1989-06-13 EP EP89420209A patent/EP0347345B2/en not_active Expired - Lifetime
- 1989-06-14 JP JP1152015A patent/JPH0284932A/en active Pending
-
1999
- 1999-07-12 JP JP005178U patent/JPH11154U/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5143881A (en) * | 1974-07-19 | 1976-04-14 | Medicor Muevek | TOKUNIJUSHOKANJANOSHUCHUKANSHINIMOCHIIRUKIKENYOTAININSHIKYOHOHO OYOBI SOCHI |
| JPS5151192A (en) * | 1974-10-29 | 1976-05-06 | Tokyo Shibaura Electric Co | |
| JPS57150944A (en) * | 1981-03-13 | 1982-09-17 | Nippon Koden Kogyo Kk | Monitor and alarm apparatus for cardiac pulses |
| JPS6092769A (en) * | 1983-10-27 | 1985-05-24 | 株式会社メデクス | Apparatus for treating blood in outside of living body |
| JPH01126978A (en) * | 1987-10-30 | 1989-05-19 | Henry Ford Hospital | Automated method for controlling dialysis of blood according to blood pressure and heart rate of patient |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014117537A (en) * | 2012-12-18 | 2014-06-30 | Fujitsu Ltd | Waveform detecting device, waveform detecting method, and waveform detecting program |
Also Published As
| Publication number | Publication date |
|---|---|
| IT1219379B (en) | 1990-05-11 |
| EP0347345B2 (en) | 1999-06-09 |
| DE68918167D1 (en) | 1994-10-20 |
| EP0347345B1 (en) | 1994-09-14 |
| JPH11154U (en) | 1999-12-10 |
| DE68918167T2 (en) | 1995-01-12 |
| EP0347345A1 (en) | 1989-12-20 |
| IT8867564A0 (en) | 1988-06-15 |
| ES2058584T3 (en) | 1994-11-01 |
| ES2058584T5 (en) | 1999-10-16 |
| DE68918167T3 (en) | 2000-02-03 |
| US4967754A (en) | 1990-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0284932A (en) | Apparatus for estimating manifestation itself of side effect in patient during dialytic treatment | |
| US5058599A (en) | Method and apparatus for detecting a sequence of abnormal events in an electrical signal, particularly in the depolarization signal of a heart | |
| JP5593473B2 (en) | Autonomic nerve function diagnostic device, biological monitoring system and program | |
| US6882166B2 (en) | System and method for measuring the validity of a bioelectric impedance measurement in the presence of interference | |
| US4765340A (en) | Apnea detector | |
| US5355889A (en) | Monitoring system for producing patient status indicator | |
| Kero et al. | Decreased heart rate variation in decerebration syndrome: quantitative clinical criterion of brain death? | |
| US20060247501A1 (en) | System and method for detecting signal artifacts | |
| US9498162B2 (en) | Identifying seizures using heart data from two or more windows | |
| EP2072005A1 (en) | System for determining and monitoring desaturation indices and instantaneous respiratory rate | |
| AU2002327200A1 (en) | System and method for measuring bioelectric impedance in the presence of interference | |
| US7991456B2 (en) | Systems and methods for managing heart rate dependent conditions | |
| EP1584288B1 (en) | Active implantable medical device comprising means for diagnosis of respiratory conditions, having enhanced detection of respiratory artifacts | |
| US20130204105A1 (en) | Method and apparatus for monitoring a blood oxygen saturation level relative to a saturation threshold value | |
| Nollo et al. | Spontaneous beat-to-beat variability of the ventricular repolarization duration | |
| US4784153A (en) | Method of and apparatus for detecting cardiac rhythm disturbance | |
| CA2888513A1 (en) | Device and method for detecting and reporting of a stress condition of a person | |
| US20120277603A1 (en) | Device and Method for Detecting and reporting of a stress condition of a person | |
| US5033475A (en) | Portable electrocardiographic recording analyzer for monitoring discontinuous time periods of waveforms | |
| US12527513B2 (en) | Apparatus and method for measuring level of brain cell activity under induced artificial blood circulation | |
| JPH0461849A (en) | Peripheral circulation detecting device | |
| JPH02237544A (en) | Oximeter | |
| WO2017099749A1 (en) | Method and system of measurement, correlation, and analysis of simultaneous and independent parasympathetic and sympathetic autonomic nervous system activity | |
| CN110575159A (en) | Signal baseline resetting method and device and monitor | |
| DE112017007254T5 (en) | Blood pressure monitor, assessment system and method for controlling a blood pressure monitor |